Paul Blanchfield
Presidente presso LANTHEUS HOLDINGS, INC.
Patrimonio netto: 7 M $ in data 30/04/2024
Posizioni attive di Paul Blanchfield
Società | Posizione | Inizio | Fine |
---|---|---|---|
LANTHEUS HOLDINGS, INC. | Presidente | 20/03/2023 | - |
Direttore operativo | 15/06/2022 | 20/03/2023 | |
Corporate Officer/Principal | 27/01/2020 | 15/06/2022 |
Storia della carriera di Paul Blanchfield
Precedenti posizioni note di Paul Blanchfield
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | - | - |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Formazione di Paul Blanchfield
Stanford University | Graduate Degree |
Duke University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Giappone | 2 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
President | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
LANTHEUS HOLDINGS, INC. | Health Technology |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
Aziende private | 1 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
- Borsa valori
- Insiders
- Paul Blanchfield
- Esperienza